🇺🇸 FDA
Patent

US 10668024

Mesoporous silica nanoparticles for biomedical applications

granted A61KA61K31/337A61K31/4375

Quick answer

US patent 10668024 (Mesoporous silica nanoparticles for biomedical applications) held by The Regents of the University of California expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/337, A61K31/4375, A61K49/0002, A61K49/0043